Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer
Hsing‐Ju Wu, Pei‐Yi Chu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 636-636
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Biomarkers in Breast Cancer: An Old Story with a New End
Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1364-1364
Open Access | Times Cited: 50
Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications
Samia Afzal, Muhammad Hassan, Safi Ullah, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 63
Classic and New Markers in Diagnostics and Classification of Breast Cancer
Roman Beňačka, Daniela Szabóová, Zuzana Guľašová, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5444-5444
Open Access | Times Cited: 59
Pan-inhibition of the three H2S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer
Alyaa Dawoud, R.A. Youness, Heba Nafea, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Glycolysis-Related LINC02432/Hsa-miR-98–5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma
Peng Tan, Mo Li, Zhuoran Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
TWEAK/Fn14 signalling driven super-enhancer reprogramming promotes pro-metastatic metabolic rewiring in triple-negative breast cancer
Nicholas Sim, Jean-Michel Carter, Kamalakshi Deka, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Protein biomarkers for diagnosis of breast cancer
Emeka Iweala, Doris Nnenna Amuji, Faith Chinasaokwu Nnaji
Scientific African (2024) Vol. 25, pp. e02308-e02308
Open Access | Times Cited: 4
Gold Nanobiosensors: Pioneering Breakthroughs in Precision Breast Cancer Detection
Soheil Sadr, Ashkan Hajjafari, Abbas Rahdar, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100238-100238
Open Access | Times Cited: 4
Silk fibroin: An innovative protein macromolecule-based hydrogel/scaffold revolutionizing breast cancer treatment and diagnosis – Mechanisms, advancements, and targeting capabilities
Shubhrajit Mantry, Kotaiah Silakabattini, Prabhat Kumar Das, et al.
International Journal of Biological Macromolecules (2025), pp. 142870-142870
Closed Access
Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer
Bingxin Li, Tian Yao, Min Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
Ana Julia Aguiar de Freitas, Rhafaela Lima Causin, Muriele Bertagna Varuzza, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5477-5477
Open Access | Times Cited: 24
CmP signaling network unveils novel biomarkers for triple negative breast cancer in African American women
Johnathan Abou‐Fadel, Brian Grajeda, Xiaoting Jiang, et al.
Cancer Biomarkers (2022) Vol. 34, Iss. 4, pp. 607-636
Open Access | Times Cited: 17
Breast Cancer Screening and Prophylactic Mastectomy for High-Risk Women in Romania
Claudiu Ioan Filip, Andreea Cătană, Enikő Kutasi, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 570-570
Open Access | Times Cited: 3
CmP Signaling Network Leads to Identification of Prognostic Biomarkers for Triple-Negative Breast Cancer in Caucasian Women
Johnathan Abou‐Fadel, Muaz Bhalli, Brian Grajeda, et al.
Genetic Testing and Molecular Biomarkers (2022) Vol. 26, Iss. 4, pp. 198-219
Closed Access | Times Cited: 15
Understanding Fibroadenoma of the Breast: A Comprehensive Review of Pre-operative and Post-operative Clinicopathological Correlations
Pranam Pandit, Siddhant P Murkey, Akash Agarwal, et al.
Cureus (2023)
Open Access | Times Cited: 9
Legumain inhibitor prevents breast cancer bone metastasis by attenuating osteoclast differentiation and function
Jun Song Chen, Wenke Xu, Kaiyuan Song, et al.
Bone (2023) Vol. 169, pp. 116680-116680
Closed Access | Times Cited: 8
Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer
Mohamed El‐Tanani, Angela Platt‐Higgins, Hamdi Nsairat, et al.
Life Sciences (2023) Vol. 329, pp. 121964-121964
Closed Access | Times Cited: 8
Local delivery of biocompatible lentinan/chitosan composite for prolonged inhibition of postoperative breast cancer recurrence
Saisai Gu, Jingya Xu, Wangtianzi Teng, et al.
International Journal of Biological Macromolecules (2021) Vol. 194, pp. 233-245
Closed Access | Times Cited: 16
Circular RNA circPTK2 modulates migration and invasion via miR-136/NFIB signaling on triple-negative breast cancer cells in vitro
Meng Wang, Di Chen, Hanchao Zhang, et al.
Inflammation Research (2022) Vol. 71, Iss. 4, pp. 409-421
Closed Access | Times Cited: 12
PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer
Jufang Guo, Xuelian Du, Chaolin Li
BioMed Research International (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 12
Drug Metabolism for the Identification of Clinical Biomarkers in Breast Cancer
Bárbara Costa, Nuno Vale
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3181-3181
Open Access | Times Cited: 11
The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway
Hongkun Li, Jiawei Li, Yifan Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
ARHGAP25 suppresses the development of breast cancer by an ARHGAP25/Wnt/ASCL2 feedback loop
Sijia Han, Xueying Jin, Tianyu Hu, et al.
Carcinogenesis (2023) Vol. 44, Iss. 5, pp. 369-382
Closed Access | Times Cited: 6
MALDI-TOF/MS Analysis of Extracellular Vesicles Released by Cancer Cells
Carlo Zambonin
Applied Sciences (2022) Vol. 12, Iss. 12, pp. 6149-6149
Open Access | Times Cited: 8
Integration of transcriptomics and machine learning for insights into breast cancer: exploring lipid metabolism and immune interactions
Xiaohan Chen, Jinfeng Yi, Lili Xie, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top